STOCK TITAN

InterCure to Present in Benzinga Cannabis Capital Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

InterCure Ltd (NASDAQ: INCR) announced that CEO Alexander Rabinovitch will present at the Benzinga Cannabis Capital Conference on October 14, 2021, at 1:50 PM ET, with a repeat on October 15 at the same time. Additionally, he will participate in a panel discussion on the expansion of cannabis in European markets on October 15 at 2:10 PM ET. Interested attendees can view the presentation and panel online. InterCure, operating as Canndoc, is Israel’s largest licensed cannabis producer and is recognized for its GMP-certified medical cannabis products.

Positive
  • None.
Negative
  • None.

NEW YORK and TORONTO and HERZLIYA, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will present at the Benzinga Cannabis Capital Conference on Thursday, October 14, 2021 at 1:50pm ET. The presentation will be shown again on October 15th at 1:50pm ET. In addition, Mr. Rabinovitch will participate in a live panel discussion titled, “International Spotlight – Continued Cannabis Expansion in European Markets” on Friday, October 15 at 2:10pm ET. To view the Company presentation, please click the following link: https://youtu.be/8JtjK9-IW80. To watch the live panel discussion, please click the following link: https://youtu.be/9gEdUHA8T0g.

Management will be available for virtual one-on-one meetings with registered conference attendees. To register for the conference, please visit the conference website: https://www.benzinga.com/events/cannabis/october-2021/#who-attends

If you are interested in scheduling a one-on-one meeting with InterCure’s management team, please contact InterCure@kcsa.com.

About InterCure (dba Canndoc)

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

For more information, visit: http://www.intercure.co.

To be added to InterCure’s email distribution list, please email InterCure@kcsa.com with “InterCure” in the subject.

Contact:

InterCure Ltd.
Amos Cohen, Chief Financial Officer
amos@canndoc-pharma.com

KCSA Strategic Communications
Investor and Media Relations
InterCure@kcsa.com

 


FAQ

When will InterCure's CEO present at the Benzinga Cannabis Capital Conference?

CEO Alexander Rabinovitch will present on October 14, 2021, at 1:50 PM ET, with a repeat on October 15 at the same time.

What topic will InterCure's CEO discuss at the panel on October 15?

He will discuss the topic of 'International Spotlight – Continued Cannabis Expansion in European Markets' during the panel on October 15 at 2:10 PM ET.

How can I view InterCure's presentation at the Benzinga Cannabis Capital Conference?

You can view the presentation at this link: https://youtu.be/8JtjK9-IW80.

Is InterCure available for one-on-one meetings at the conference?

Yes, InterCure management will be available for virtual one-on-one meetings with registered conference attendees.

What is the significance of InterCure in the cannabis industry?

InterCure (dba Canndoc) is Israel’s largest licensed cannabis producer and one of the fastest-growing cannabis companies outside North America.

Intercure Ltd. Ordinary Shares

NASDAQ:INCR

INCR Rankings

INCR Latest News

INCR Stock Data

72.77M
27.64M
39.6%
11.61%
0.08%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Herzliya